Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jennifer Swainson

Showing results (11-20 of 34) with videos related to

Pageof 4
Sort By:
Journal of Affective Disorders|February 4, 2023
Diet and depression: A systematic review of whole dietary interventions as treatment in patients with depressionJennifer Swainson, Matthew Reeson, Usama Malik, et al.
Frontiers in Psychiatry|January 23, 2024
Use of ketamine for treatment resistant depression: updated review of literature and practical applications to a community ketamine program in Edmonton, Alberta, CanadaCarson Chrenek, Bryan Duong, Atul Khullar, et al.
Psychiatry and Clinical Psychopharmacology|August 28, 2025
Evolving Psychotherapeutic Approaches for PTSD: Beyond the Fear-Based ModelLisa Burback, Olga Winkler, Rakesh Jetly, et al.
Frontiers in Psychiatry|December 5, 2022
A survey of drug liking and cravings in patients using sublingual or intranasal ketamine for treatment resistant depression: A preliminary evaluation of real world addictive potentialBrittany Chubbs, Jay Wang, Shaina Archer, et al.
Therapeutic Advances in Psychopharmacology|March 5, 2024
Patient-reported outcomes on sleep quality and circadian rhythm during treatment with intravenous ketamine for treatment-resistant depressionRaymond Yan, Tyler Marshall, Atul Khullar, et al.
CNS Drugs|February 15, 2022
Non-parenteral Ketamine for Depression: A Practical Discussion on Addiction Potential and Recommendations for Judicious PrescribingJennifer Swainson, Larry J Klassen, Stefan Brennan, et al.
Therapeutic Advances in Psychopharmacology|May 23, 2020
Ketamine as an antidepressant: overview of its mechanisms of action and potential predictive biomarkersDmitriy Matveychuk, Rejish K Thomas, Jennifer Swainson, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|March 20, 2025
Exploring the potential of psychedelic-assisted psychotherapy for moral injury: A scoping reviewViktoriia Kurkova, Olga Winkler, Andrew Greenshaw, et al.
Psychiatry Research|May 16, 2026
Ketamine and esketamine for the prevention of postpartum depression: A systematic review and network meta-analysis, with an integrated evidence synthesisIsis Lunsky, Gilmar Gutierrez, Xena Wang, et al.
Journal of Substance Use and Addiction Treatment|May 4, 2025
Role of ketamine in the treatment of substance use disorders: A systematic reviewReinhard Janssen-Aguilar, Shakila Meshkat, Ilya Demchenko, et al.
Pageof 4

Showing results (11-20 of 34) with videos related to

Sort By:
Pageof 4
Journal of Affective Disorders|February 4, 2023
Diet and depression: A systematic review of whole dietary interventions as treatment in patients with depressionJennifer Swainson, Matthew Reeson, Usama Malik, et al.
Frontiers in Psychiatry|January 23, 2024
Use of ketamine for treatment resistant depression: updated review of literature and practical applications to a community ketamine program in Edmonton, Alberta, CanadaCarson Chrenek, Bryan Duong, Atul Khullar, et al.
Psychiatry and Clinical Psychopharmacology|August 28, 2025
Evolving Psychotherapeutic Approaches for PTSD: Beyond the Fear-Based ModelLisa Burback, Olga Winkler, Rakesh Jetly, et al.
Frontiers in Psychiatry|December 5, 2022
A survey of drug liking and cravings in patients using sublingual or intranasal ketamine for treatment resistant depression: A preliminary evaluation of real world addictive potentialBrittany Chubbs, Jay Wang, Shaina Archer, et al.
Therapeutic Advances in Psychopharmacology|March 5, 2024
Patient-reported outcomes on sleep quality and circadian rhythm during treatment with intravenous ketamine for treatment-resistant depressionRaymond Yan, Tyler Marshall, Atul Khullar, et al.
CNS Drugs|February 15, 2022
Non-parenteral Ketamine for Depression: A Practical Discussion on Addiction Potential and Recommendations for Judicious PrescribingJennifer Swainson, Larry J Klassen, Stefan Brennan, et al.
Therapeutic Advances in Psychopharmacology|May 23, 2020
Ketamine as an antidepressant: overview of its mechanisms of action and potential predictive biomarkersDmitriy Matveychuk, Rejish K Thomas, Jennifer Swainson, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|March 20, 2025
Exploring the potential of psychedelic-assisted psychotherapy for moral injury: A scoping reviewViktoriia Kurkova, Olga Winkler, Andrew Greenshaw, et al.
Psychiatry Research|May 16, 2026
Ketamine and esketamine for the prevention of postpartum depression: A systematic review and network meta-analysis, with an integrated evidence synthesisIsis Lunsky, Gilmar Gutierrez, Xena Wang, et al.
Journal of Substance Use and Addiction Treatment|May 4, 2025
Role of ketamine in the treatment of substance use disorders: A systematic reviewReinhard Janssen-Aguilar, Shakila Meshkat, Ilya Demchenko, et al.
Pageof 4